Search

Your search keyword '"Capobianchi Mr"' showing total 620 results

Search Constraints

Start Over You searched for: Author "Capobianchi Mr" Remove constraint Author: "Capobianchi Mr"
620 results on '"Capobianchi Mr"'

Search Results

1. Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents

2. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020

4. Gender differences in the use of cardiovascular interventions in HIV?positive persons; the D:A:D Study

5. Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization

6. Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART

9. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

10. Geographical Variability Affects CCHFV Detection by RT-PCR: A Tool for In-Silico Evaluation of Molecular Assays

11. Laboratory management of Crimean-Congo haemorrhagic fever virus infections: perspectives from two European networks

12. Incidence of Malignancies in HIV‐Infected Patients and Prognostic Role of Current CD4 Cell Count: Evidence from a Large Italian Cohort Study

13. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016

14. The European Virus Archive goes global: A growing resource for research

15. Erratum: Imported arboviral infections in Italy, July 2014-October 2015: A National Reference Laboratory report [BMC Infect. Dis. 17, (2017)(216)] DOI: 10.1186/s12879-017-2320-1

17. Quantitative HIV-1 proviral DNA detection: a multicentre analysis

18. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study

19. Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: a longitudinal study

20. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

21. Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008

22. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014

23. Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients

24. Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients

25. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

26. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients

27. Development of a definition for rapid progression (RP) of renal function in HIV-positive persons:the D:A:D study

28. Pregnancy Outcomes Among ART-Naive and ART-Experienced HIV-Positive Women: Data From the ICONA Foundation Study Group, Years 1997-2013

29. Human Immunodeficiency Virus (HIV) DNA Load and Level of Immunosuppression in Treatment‐Naive HIV‐1–Infected Patients

30. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy

31. Performance of genotypic tropism testing on proviral DNAin clinical practice: results from the DIVA Study Group

32. Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts

33. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure

34. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

35. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count

36. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure

37. Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI

38. HEFFICON: HIV effectiveness Italian conference

39. Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome

40. Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study

41. Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients

42. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study

43. Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures

45. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

46. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis

47. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients

48. Multicenter quality control study for human cytomegalovirus DNAemia quantification

49. Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina

50. Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis

Catalog

Books, media, physical & digital resources